Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103633410> ?p ?o ?g. }
- W2103633410 endingPage "95" @default.
- W2103633410 startingPage "89" @default.
- W2103633410 abstract "Within 4 years of the discovery of anaplastic lymphoma kinase (ALK) rearrangements in non-small cell lung cancer (NSCLC), the ALK inhibitor crizotinib gained US and European approval for the treatment of advanced ALK-positive NSCLC. This was due to the striking response data observed with crizotinib in phase I and II trials in patients with ALK-positive NSCLC, as well as the favorable tolerability and safety profile observed. Recently published phase III data established crizotinib as a new standard of care for this NSCLC molecular subset. A consequence of such rapid approval, however, is the limited clinical experience and relative paucity of information concerning optimal therapy management. In this review, we discuss the development of crizotinib and the clinical relevance of its safety profile, examining crizotinib-associated adverse events in detail and making specific management recommendations. Crizotinib-associated adverse events were mostly mild to moderate in severity in clinical studies, and appropriate monitoring and supportive therapies are considered effective in avoiding the need for dose interruption or reduction in most cases. Therapy management of patients following disease progression on crizotinib is also discussed. Based on available clinical data, it is evident that patients may have prolonged benefit from crizotinib after Response Evaluation Criteria in Solid Tumors-defined disease progression, and crizotinib should be continued for as long as the patient derives benefit." @default.
- W2103633410 created "2016-06-24" @default.
- W2103633410 creator A5001928949 @default.
- W2103633410 creator A5003309897 @default.
- W2103633410 creator A5011117439 @default.
- W2103633410 creator A5017669437 @default.
- W2103633410 creator A5028871436 @default.
- W2103633410 creator A5029761367 @default.
- W2103633410 creator A5033192979 @default.
- W2103633410 creator A5039170999 @default.
- W2103633410 creator A5043549118 @default.
- W2103633410 creator A5065110382 @default.
- W2103633410 creator A5070375776 @default.
- W2103633410 creator A5078251366 @default.
- W2103633410 creator A5083786421 @default.
- W2103633410 creator A5087050668 @default.
- W2103633410 date "2015-02-01" @default.
- W2103633410 modified "2023-10-03" @default.
- W2103633410 title "Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus" @default.
- W2103633410 cites W1513785617 @default.
- W2103633410 cites W1515180961 @default.
- W2103633410 cites W1592490662 @default.
- W2103633410 cites W1676400576 @default.
- W2103633410 cites W1719751125 @default.
- W2103633410 cites W1967645636 @default.
- W2103633410 cites W1973016854 @default.
- W2103633410 cites W1973947576 @default.
- W2103633410 cites W1974903221 @default.
- W2103633410 cites W1981676561 @default.
- W2103633410 cites W2010619956 @default.
- W2103633410 cites W2030227571 @default.
- W2103633410 cites W2038056960 @default.
- W2103633410 cites W2050249255 @default.
- W2103633410 cites W2055402151 @default.
- W2103633410 cites W2072816958 @default.
- W2103633410 cites W2096156234 @default.
- W2103633410 cites W2104830962 @default.
- W2103633410 cites W2111724182 @default.
- W2103633410 cites W2113327188 @default.
- W2103633410 cites W2128208856 @default.
- W2103633410 cites W2130488043 @default.
- W2103633410 cites W2132123717 @default.
- W2103633410 cites W2134787029 @default.
- W2103633410 cites W2136549983 @default.
- W2103633410 cites W2139483106 @default.
- W2103633410 cites W2150424194 @default.
- W2103633410 cites W2167665047 @default.
- W2103633410 cites W2168691181 @default.
- W2103633410 cites W2293461114 @default.
- W2103633410 cites W4238604577 @default.
- W2103633410 cites W4242648511 @default.
- W2103633410 doi "https://doi.org/10.1016/j.lungcan.2014.12.010" @default.
- W2103633410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25576294" @default.
- W2103633410 hasPublicationYear "2015" @default.
- W2103633410 type Work @default.
- W2103633410 sameAs 2103633410 @default.
- W2103633410 citedByCount "39" @default.
- W2103633410 countsByYear W21036334102015 @default.
- W2103633410 countsByYear W21036334102016 @default.
- W2103633410 countsByYear W21036334102017 @default.
- W2103633410 countsByYear W21036334102018 @default.
- W2103633410 countsByYear W21036334102019 @default.
- W2103633410 countsByYear W21036334102020 @default.
- W2103633410 countsByYear W21036334102021 @default.
- W2103633410 countsByYear W21036334102022 @default.
- W2103633410 crossrefType "journal-article" @default.
- W2103633410 hasAuthorship W2103633410A5001928949 @default.
- W2103633410 hasAuthorship W2103633410A5003309897 @default.
- W2103633410 hasAuthorship W2103633410A5011117439 @default.
- W2103633410 hasAuthorship W2103633410A5017669437 @default.
- W2103633410 hasAuthorship W2103633410A5028871436 @default.
- W2103633410 hasAuthorship W2103633410A5029761367 @default.
- W2103633410 hasAuthorship W2103633410A5033192979 @default.
- W2103633410 hasAuthorship W2103633410A5039170999 @default.
- W2103633410 hasAuthorship W2103633410A5043549118 @default.
- W2103633410 hasAuthorship W2103633410A5065110382 @default.
- W2103633410 hasAuthorship W2103633410A5070375776 @default.
- W2103633410 hasAuthorship W2103633410A5078251366 @default.
- W2103633410 hasAuthorship W2103633410A5083786421 @default.
- W2103633410 hasAuthorship W2103633410A5087050668 @default.
- W2103633410 hasBestOaLocation W21036334101 @default.
- W2103633410 hasConcept C117643217 @default.
- W2103633410 hasConcept C121608353 @default.
- W2103633410 hasConcept C126322002 @default.
- W2103633410 hasConcept C143998085 @default.
- W2103633410 hasConcept C197934379 @default.
- W2103633410 hasConcept C2776232967 @default.
- W2103633410 hasConcept C2776256026 @default.
- W2103633410 hasConcept C2778347629 @default.
- W2103633410 hasConcept C2778375690 @default.
- W2103633410 hasConcept C2779220645 @default.
- W2103633410 hasConcept C2779422266 @default.
- W2103633410 hasConcept C2781230642 @default.
- W2103633410 hasConcept C535046627 @default.
- W2103633410 hasConcept C71924100 @default.
- W2103633410 hasConceptScore W2103633410C117643217 @default.
- W2103633410 hasConceptScore W2103633410C121608353 @default.
- W2103633410 hasConceptScore W2103633410C126322002 @default.